Taiwan’s health authorities have suspended the administration of a second dose of the Pfizer-BioNtech COVID vaccine to children aged 12 to 17 years, citing concerns about an increased risk of heart inflammation.
According to Chen Shih-chung, head of the country’s Central Epidemic Command Center (CECC), a panel of experts on Wednesday decided to stop responding to the teenagers. The health authority opted for a second discontinuation due to concerns about an increased risk of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the outer layer of the heart).
The Advisory Committee for Immunization Practices of the Ministry of Health and Welfare said that it is prohibiting giving a second dose of vaccination to children aged 12 to 17 years for a period of two weeks. During that time, experts from the country’s Centers for Disease Control will investigate 16 reported myocarditis cases among Taiwanese teens receiving the jab.
Children under 11 years of age will not be vaccinated until any potential problems with giving second doses to teenagers are fully understood, Chen said, and international data will also be considered. The director of the CECC noted that Hong Kong and the UK are the only countries that are not immunizing children aged 12 to 17 with a double dose.
US Center for Disease Control famous reported cases of myocarditis in recipients of mRNA COVID vaccines such as Pfizer, “Especially in male adolescents and young adults” and what happened “More often after the second dose”.
Like this story? Share it with a friend!